Patient and Scientific Review Board

Granting access to data from clinical trials sponsored by LEO Pharma shall be made for scientific purposes. This is why the main task of the Patient and Scientific Review Board is to evaluate requests for data based on the scientific rationale behind the request.

On this site, information about the composition of the Patient and Scientific Review Board, their working procedures, and their previous decisions are made available.

a. The Patient and Scientific Review Board Charter

The Charter explains the procedures and decision making process of the Patient and Scientific Review Board.

b. Dates for Board meetings: 

2018

2nd of May

6th of September

29th of November

 

For being evaluated at a board meeting, a complete research proposal has to have been submitted via the clinical trial disclosure mailbox at least 30 working days ahead of the meeting. 

 

We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.